Dublin, March 21, 2023 (GLOBE NEWSWIRE) -- The "Cell Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
This report provides strategists, marketers and senior management with the critical information they need to assess the market.
The global cell therapy market is expected to grow from $9.02 billion in 2021 to $10.74 billion in 2022 at a compound annual growth rate (CAGR) of 19%. The cell therapy market is expected to reach $19.75 billion in 2026 at a CAGR of 16.5%.
Major players in the cell therapy market are Fibrocell Science Inc., JCR Pharmaceuticals Co. Ltd., PHARMICELL Co. Ltd., Osiris Therapeutics Inc., MEDIPOST, Vericel Corporation, Anterogen Co. Ltd., KolonTissueGene Inc., Stemedica Cell Technologies Inc. and AlloCure.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The cell therapy market includes revenues earned by entities by enhancing the growth of new healthy skin tissue and enhancing collagen production. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Cell therapy refers to the replacement or repair of damaged tissue and/or cells through the transplantation of human cells. Numerous different types of cells may be used as part of a therapy or treatment for a number of diseases and disorders with the help of new technologies, inventive products, and infinite imagination. It is a form of treatment wherein a patient receives live cells via injection, grafting, or implant in order to produce a therapeutic result.
The main techniques used in cell therapy are stem cell therapy, cell vaccine, adoptive cell transfer (act), fibroblast cell therapy, and chondrocyte cell therapy. Stem cell treatment, also known as regenerative medicine, uses stem cells or their derivatives to stimulate the healing response of sick, defective, or wounded tissue. The different types of therapies include allogeneic therapies, and autologous therapies and are used in various applications such as oncology, cardiovascular disease (CVD), orthopedic, wound healing, and others.
The rising prevalence of chronic diseases contributed to the growth of the cell therapy market. According to the US Centers for Disease Control and Prevention (CDC), chronic disease is a condition that lasts for one year or more, requires medical attention, limits daily activities, or both, and includes heart disease, cancer, diabetes, and Parkinson's disease. Stem cells can benefit patients suffering from spinal cord injuries, type 1 diabetes, Parkinson's disease (PD), heart disease, cancer, and osteoarthritis.
The high cost of cell therapy hindered the growth of the cell therapy market. Cell therapies have become a common choice of treatment in recent years as people are looking for the newest treatment options. Although there is a huge increase in demand for cell therapies, they are still very costly to try. Basic joint injections can cost about $1,000 and, based on the condition, more specialized procedures can cost up to $ 100,000. In 2020, the average cost of stem cell therapy can range from $4000 - $8,000 in the USA. Therefore, the high cost of cell therapy restraints the growth of the cell therapy market.
Key players in the market are strategically partnering and collaborating to expand the product portfolio and geographical presence of the company.
For instance, in October 2021, Takeda, a Japan-based pharmaceutical company acquired GammaDelta Therapeutics, a US-based company that offers cell therapies, to speed up the development of allogeneic T cell therapies for solid tumours. Furthermore, in November 2020, Sanofi, a US-based pharmaceutical company acquired Kiadis, a Netherlands-based pharmaceutical company, to boost cell therapy which is used to develop treatments for life-threatening diseases.
In October 2021, Takeda Pharmaceutical Company Limited, a Japan based pharmaceutical company specializing in drug development and commercialization, acquired GammaDelta Therapeutics Limited for an amount of $100 million.
Through this acquisition, Takeda will acquire early-stage cell therapy programs in addition to GammaDelta's allogeneic variable delta 1 (V1) gamma-delta T cell therapy platforms, which encompass both blood-derived and tissue-derived platforms. GammaDelta Therapeutics Limited is a UK-based biotechnology company specializing in the research and development of T-cell therapy and immunotherapy for cancer treatment.
The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2022 - 2026 |
| Estimated Market Value (USD) in 2022 | $10.74 billion |
| Forecasted Market Value (USD) by 2026 | $19.75 billion |
| Compound Annual Growth Rate | 16.5% |
| Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. Cell Therapy Market Characteristics
3. Cell Therapy Market Trends And Strategies
4. Cell Therapy Market - Macro Economic Scenario
4.1 COVID-19 Impact On Cell Therapy Market
4.2 Ukraine-Russia War Impact On Cell Therapy Market
4.3 Impact Of High Inflation On Cell Therapy Market
5. Cell Therapy Market Size And Growth
5.1. Global Cell Therapy Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Cell Therapy Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Cell Therapy Market Segmentation
6.1. Global Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Stem Cell Therapy
- Cell Vaccine
- Adoptive Cell Transfer (ACT)
- Fibroblast Cell Therapy
- Chondrocyte Cell Therapy
6.2. Global Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Allogeneic Therapies
- Autologous Therapies
6.3. Global Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Oncology
- Cardiovascular Disease (CVD)
- Orthopedic
- Wound Healing
- Other Applications
7. Cell Therapy Market Regional And Country Analysis
7.1. Global Cell Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Cell Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/3jsgv9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
